Avanos Medical, Inc.AVNSNYSE
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank85
3Y CAGR+102.3%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+102.3%/yr
vs -22.6%/yr prior
Acceleration
+124.9pp
Accelerating
Percentile
P85
Within normal range
vs 3Y Ago
8.3x
Strong expansion
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 204.29% |
| Q3 2025 | 266.67% |
| Q2 2025 | -122.11% |
| Q1 2025 | -64.22% |
| Q4 2024 | 165.50% |
| Q3 2024 | -8.68% |
| Q2 2024 | 280.99% |
| Q1 2024 | -277.94% |
| Q4 2023 | -73.02% |
| Q3 2023 | 481.82% |
| Q2 2023 | 38.89% |
| Q1 2023 | -137.50% |
| Q4 2022 | 24.68% |
| Q3 2022 | 0.87% |
| Q2 2022 | 815.63% |
| Q1 2022 | -106.75% |
| Q4 2021 | 157.61% |
| Q3 2021 | 93.68% |
| Q2 2021 | 205.56% |
| Q1 2021 | -125.00% |
| Q4 2020 | -110.53% |
| Q3 2020 | 67.24% |
| Q2 2020 | 47.27% |
| Q1 2020 | 0.00% |
| Q4 2019 | 53.59% |
| Q3 2019 | 56.75% |
| Q2 2019 | -53.93% |
| Q1 2019 | -41.83% |
| Q4 2018 | 68.03% |
| Q3 2018 | 27.18% |
| Q2 2018 | -745.51% |
| Q1 2018 | -67.57% |
| Q4 2017 | 447.87% |
| Q3 2017 | -29.32% |
| Q2 2017 | -50.37% |
| Q1 2017 | -28.53% |
| Q4 2016 | -11.35% |
| Q3 2016 | -6.83% |
| Q2 2016 | 31.59% |
| Q1 2016 | 102.94% |